Therapeutic interventions to restore microcirculatory perfusion following experimental hemorrhagic shock and fluid resuscitation: A systematic review.

Microcirculation : the Official Journal of the Microcirculatory Society, Inc
Anoek L I van LeeuwenCharissa E van den Brom

Abstract

Microcirculatory perfusion disturbances following hemorrhagic shock and fluid resuscitation contribute to multiple organ dysfunction and mortality. Standard fluid resuscitation is insufficient to restore microcirculatory perfusion; however, additional therapies are lacking. We conducted a systematic search to provide an overview of potential non-fluid-based therapeutic interventions to restore microcirculatory perfusion following hemorrhagic shock. A structured search of PubMed, EMBASE, and Cochrane Library was performed in March 2020. Animal studies needed to report at least one parameter of microcirculatory flow (perfusion, red blood cell velocity, functional capillary density). The search identified 1269 records of which 48 fulfilled all eligibility criteria. In total, 62 drugs were tested of which 29 were able to restore microcirculatory perfusion. Particularly, complement inhibitors (75% of drugs tested successfully restored blood flow), endothelial barrier modulators (100% successful), antioxidants (66% successful), drugs targeting cell metabolism (83% successful), and sex hormones (75% successful) restored microcirculatory perfusion. Other drugs consisted of attenuation of inflammation (100% not successful), vasoactive a...Continue Reading

References

Mar 1, 1992·Canadian Journal of Physiology and Pharmacology·P WangI H Chaudry
Feb 1, 1985·Proceedings of the Society for Experimental Biology and Medicine·R B LechnerD G Reynolds
May 1, 1996·World Journal of Surgery·G RegelH Tscherne
Jan 1, 1995·Journal of Cardiovascular Pharmacology·J Barroso-ArandaG W Schmid-Schönbein
Jan 22, 1998·The American Journal of Physiology·C BauerW A Buurman
May 30, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Markus PaxianMichael Bauer
Jul 29, 2004·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·S Bertuglia, A Giusti
Sep 10, 2004·American Journal of Physiology. Cell Physiology·Paul S BrookesShey-Shing Sheu
Nov 20, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Zheng F BaIrshad H Chaudry
Sep 13, 2005·Surgery·El Rasheid ZakariaR Neal Garrison
Dec 24, 2005·Physiological Reviews·Dolly Mehta, Asrar B Malik
Mar 8, 2006·Critical Care Medicine·Rene SchmidtBenedikt H J Pannen
Mar 6, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Mie HiratsukaMasaharu Ito
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Aug 18, 2009·Journal of Critical Care·Bryan CollierJohn Morris
Nov 26, 2010·American Journal of Respiratory and Critical Care Medicine·Steven M Hollenberg
Dec 25, 2010·Critical Care : the Official Journal of the Critical Care Forum·Andrea MorelliMartin Westphal
Feb 1, 2011·The Journal of Surgical Research·Sergey B ZaetsEva H Olsen
Nov 15, 2011·Critical Care Medicine·Anton A IgoninPaul Herscu
Jun 30, 2012·The Journal of Trauma and Acute Care Surgery·Sisse R Ostrowski, Pär I Johansson
Feb 25, 2014·Critical Care Medicine·Guillaume TachonJacques Duranteau
Mar 29, 2014·BMC Medical Research Methodology·Carlijn R HooijmansMiranda W Langendam
Aug 31, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Liangming LiuTao Li

❮ Previous
Next ❯

Software Mentioned

Excel
SYRCLE
PRISMA

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Critical Care : the Official Journal of the Critical Care Forum
Michael J MasseyProCESS investigators
© 2021 Meta ULC. All rights reserved